NSAM
North Star Asset Management Portfolio holdings
AUM
$2.36B
This Quarter Return
+5.18%
1 Year Return
+14.42%
3 Year Return
+63.82%
5 Year Return
+104.72%
10 Year Return
+249.93%
AUM
$1.67B
AUM Growth
+$1.67B
(+5.3%)
Cap. Flow
+$15.1M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
22.22%
Holding
290
New
11
Increased
77
Reduced
133
Closed
7
Top Buys
| 1 |
Costco
COST
|
$5.19M |
| 2 |
10x Genomics
TXG
|
$3.54M |
| 3 |
Avantor
AVTR
|
$3.26M |
| 4 |
Zscaler
ZS
|
$2.99M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$2.88M |
Top Sells
| 1 |
Travel + Leisure Co
TNL
|
$4.24M |
| 2 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$3.75M |
| 3 |
ACI Worldwide
ACIW
|
$2.62M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$1.77M |
| 5 |
Hanesbrands
HBI
|
$1.65M |
Sector Composition
| 1 | Technology | 26.13% |
| 2 | Financials | 14.1% |
| 3 | Healthcare | 12.86% |
| 4 | Industrials | 9.04% |
| 5 | Consumer Discretionary | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
SPDR S&P Bank ETF
KBE
$1.6B
| $895K | 0.05% |
17,242
-275
| -2% | -$14.3K |
|
152
Henry Schein
HSIC
$8.14B
| $877K | 0.05% |
12,663
-100
| -0.8% | -$6.93K |
|
153
Merck
MRK
$210B
| $871K | 0.05% |
11,835
-120
| -1% | -$8.83K |
|
154
McKesson
MCK
$85.9B
| $867K | 0.05% |
4,445
| – | – |
|
|
ATVI
155
DELISTED
Activision Blizzard Inc.
ATVI
| $859K | 0.05% |
9,237
-20
| -0.2% | -$1.86K |
|
156
GE Aerospace
GE
$293B
| $814K | 0.05% |
12,426
-130
| -1% | -$8.52K |
|
157
W.W. Grainger
GWW
$48.7B
| $802K | 0.05% |
2,000
| – | – |
|
158
Novo Nordisk
NVO
$252B
| $799K | 0.05% |
23,704
| – | – |
|
159
Vertex Pharmaceuticals
VRTX
$102B
| $784K | 0.05% |
3,650
| – | – |
|
160
IBM
IBM
$227B
| $783K | 0.05% |
6,148
+225
| +4% | +$28.7K |
|
161
Yum China
YUMC
$16.3B
| $783K | 0.05% |
13,231
-30
| -0.2% | -$1.78K |
|
162
Exelixis
EXEL
$9.95B
| $779K | 0.05% |
34,500
| – | – |
|
163
UnitedHealth
UNH
$279B
| $757K | 0.05% |
2,035
| – | – |
|
164
McDonald's
MCD
$226B
| $690K | 0.04% |
3,078
-10
| -0.3% | -$2.24K |
|
|
IIF
165
Morgan Stanley India Investment Fund
IIF
$253M
| $682K | 0.04% |
29,256
-3,552
| -11% | -$82.8K |
|
166
Incyte
INCY
$17B
| $670K | 0.04% |
8,250
| – | – |
|
167
AT&T
T
$208B
| $664K | 0.04% |
29,060
+214
| +0.7% | +$4.89K |
|
|
WBA
168
DELISTED
Walgreens Boots Alliance
WBA
| $664K | 0.04% |
12,105
-725
| -6% | -$39.8K |
|
169
Wells Fargo
WFC
$258B
| $663K | 0.04% |
16,963
+240
| +1% | +$9.38K |
|
170
Royce Value Trust
RVT
$1.92B
| $659K | 0.04% |
36,414
-3,515
| -9% | -$63.6K |
|
171
Ionis Pharmaceuticals
IONS
$9.64B
| $618K | 0.04% |
13,753
-20
| -0.1% | -$899 |
|
172
Medtronic
MDT
$118B
| $609K | 0.04% |
5,158
-134
| -3% | -$15.8K |
|
173
Caterpillar
CAT
$194B
| $600K | 0.04% |
2,590
| – | – |
|
174
Starbucks
SBUX
$99.2B
| $594K | 0.04% |
5,435
-25
| -0.5% | -$2.73K |
|
175
Colgate-Palmolive
CL
$67.7B
| $590K | 0.04% |
7,486
-280
| -4% | -$22.1K |
|